An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer
S Brönimann, B Pradere, P Karakiewicz… - Expert Review of …, 2020 - Taylor & Francis
Introduction This manuscript aims to give an overview of current diagnostic, staging, and
prognostic markers for prostate cancer (PCa) and discuss emerging approaches. The …
prognostic markers for prostate cancer (PCa) and discuss emerging approaches. The …
Novel tools for prostate cancer prognosis, diagnosis, and follow‐up
A Dimakakos, A Armakolas… - BioMed research …, 2014 - Wiley Online Library
Prostate‐specific antigen (PSA) is the main diagnostic tool when it comes to prostate cancer
but it possesses serious limitations. Therefore, there is an urgent need for more sensitive …
but it possesses serious limitations. Therefore, there is an urgent need for more sensitive …
Novel diagnostic biomarkers of prostate cancer: an update
U Anceschi, G Tuderti, F Lugnani… - Current Medicinal …, 2019 - ingentaconnect.com
Objective: In recent years, several biomarkers alternative to standard prostate specific
antigen (PSA) for prostate cancer (PCa) diagnosis have become available. The aim of this …
antigen (PSA) for prostate cancer (PCa) diagnosis have become available. The aim of this …
Novel histopathological biomarkers in prostate cancer: implications and perspectives
P Kiełb, K Kowalczyk, A Gurwin, Ł Nowak, W Krajewski… - Biomedicines, 2023 - mdpi.com
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …
significant progress in cancer diagnosis and treatment over the last few years, the approach …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - Springer
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
Biomarkers for prostate cancer
E Schiffer - World journal of urology, 2007 - Springer
Novel biomarkers for prostate cancer (PCa) are currently being assessed for utility in PCa
diagnosis. This article aims to provide concise information on the current findings that impact …
diagnosis. This article aims to provide concise information on the current findings that impact …
Biomarkers in prostate cancer–current clinical utility and future perspectives
A Kretschmer, D Tilki - Critical reviews in oncology/hematology, 2017 - Elsevier
Current tendencies in the treatment course of prostate cancer patients increase the need for
reliable biomarkers that help in decision-making in a challenging clinical setting. Within the …
reliable biomarkers that help in decision-making in a challenging clinical setting. Within the …
Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer
CR Mazzola, T Ghoneim, SF Shariat - … Francaise D'urologie et de la …, 2010 - europepmc.org
The introduction and widespread adoption of prostate-specific antigen (PSA) has
revolutionized the way prostate cancer is diagnosed and treated. However, the use of PSA …
revolutionized the way prostate cancer is diagnosed and treated. However, the use of PSA …
[PDF][PDF] Biomarkers for determination prostate cancer: implication for diagnosis and prognosis
S Ziaran, Z Varchulova Novakova, D Bohmer… - Neoplasma, 2015 - researchgate.net
Prostate cancer (PCa) belongs to most common cancers and it is the second leading cause
of cancer death in men. A genetic predisposition or acquired genetic and epigenetic …
of cancer death in men. A genetic predisposition or acquired genetic and epigenetic …
Prognostic markers inprostate cancer
JS Ross, CE Sheehan, HAG Fisher… - Expert Review of …, 2002 - Taylor & Francis
In this review, a series of relatively well-documented ancillary biomarkers and emerging
molecular assays are evaluated for their relative ability to predict prognosis in prostate …
molecular assays are evaluated for their relative ability to predict prognosis in prostate …